APA (7th ed.) Citation

Fuchs, F., Schillinger, D., Atreya, R., Hirschmann, S., Fischer, S., Neufert, C., . . . Zundler, S. (2017). Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).

Chicago Style (17th ed.) Citation

Fuchs, Friederike, Daniela Schillinger, Raja Atreya, Simon Hirschmann, Sarah Fischer, Clemens Neufert, Imke Atreya, Markus F. Neurath, and Sebastian Zundler. Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles. Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2017.

MLA (9th ed.) Citation

Fuchs, Friederike, et al. Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2017.